-
Efficacy of chimp-vector HIV vaccine unaffected by human adenovirus antibodies,
2-21-2003.
-
Polyclonal antibody against HIV passes muster in phase I trial, 2-10-2003.
-
Active HPV-16 infection relatively uncommon in HIV-infected women in US,
1-27-2003.
-
T cell-based TB test useful even in regions with high HIV burden, 12-18-2002.
-
Dextrin sulfate safe and acceptable as a vaginal microbicide, 12-12-2002.
-
Antagonism of gp120 might treat HIV-related cognitive impairment, 12-6-2002.
-
HPV+ women with normal Pap at substantial risk of future abnormal Pap,
12-6-2002.
-
Resistant HIV becomes more resistant, but less fit, if same therapy maintained,
11-15-2002.
-
Ritonavir damage to endothelial cells may explain its adverse vascular effects,
10-25-2002.
-
Disadvantage from prior nucleoside therapy persists for years during HAART,
10-17-2002.
-
Oral candidiasis in HAART era generally caused by azole-susceptible Candida,
10-2-2002.
-
Gleevec and other c-Kit inhibitors might treat Kaposi’s sarcoma, 8-22-2002.
-
Polyprotein vaccine protects mice against cutaneous leishmaniasis, 8-15-2002.
-
Antichlamydial effect of aspirin might explain its cardioprotective activity,
8-1-2002.
-
Protease inhibitor use linked to changes in cardiac structure and function,
7-24-2002.
-
Tenofovir DF active against resistant HIV in treatment-experienced patients,
6-11-2002.
-
Fat redistribution not common in HIV-infected children receiving HAART,
6-6-2002.
-
KS-associated herpesvirus infection common in HIV-negative gay men, 4-5-2002.
-
Passive immunization via nasal mucosa protects SCID mice from pneumonia,
3-25-2002.
-
Women might have better HAART outcomes than men, 3-13-2002.
-
Reseeding of viral reservoirs may explain poor response to HAART interruption,
2-14-2002.
-
Hepatotoxicity of PIs occurs mainly in HIV patients co-infected with hepatitis,
2-7-2002.
-
Percutaneous embolotherapy controls life-threatening hemoptysis, 2-5-2002.
-
Low-cost nevirapine regimen prevents vertical HIV transmission, 7-15-1999.
-
1918 influenza virus not avian; cause of virulence still unknown, 2-17-1999.
-
Hemoglobin E trait associated with milder course of falciparum malaria,
1-6-1999.
-
Women can contract humanpapilloma virus from sex with women, 12-21-1998.
-
US colleges, universities urged to target TB screening to high-risk students,
12-18-1998.
-
Rare HIV mutation can resist all nucleoside reverse transcriptase inhibitors,
11-17-1998.
-
Pregnant women develop anti-adhesion antibodies to malaria, 10-29-1998.
-
Access to medical care prolongs AIDS-free survival among drug users, 10-26-1998.
-
AZT derivatives show promise as anti-HIV spermicides, 10-7-1998.
-
Long-term famciclovir suppresses recurrences of genital herpes simplex virus,
9-9-1998.
-
Nonoxynol-9 may potentiate rectal infection by herpes simplex virus, possibly
HIV, 8-31-1998
-
“Protein switching” by P. falciparum may affect severity of malaria, 7-23-1998.
-
Vaccine based on collagen adhesin protects mice from Staph aureus, 6-15-1998.
-
Antiviral effect of eosinophils results from secretory ribonucleases, 6-8-1998.
-
Mucosal immunization provides resistance to HSV in mice, 4-29-1998.
